Nbeal2 interacts with Dock7, Sec16a, and Vac14.

Area of Science:

• Hematology
• Molecular Biology
• Genetics

Background:

• Gray platelet syndrome (GPS) is a rare bleeding disorder linked to NBEAL2 gene mutations.
• GPS is characterized by absent platelet alpha-granules and marrow fibrosis.
• The Nbeal2 protein's function and interactions in platelet biogenesis are poorly understood.

Purpose of the Study:

• To identify proteins interacting with Nbeal2.
• To investigate the functional consequences of NBEAL2 mutations on Nbeal2 interactions.
• To elucidate the role of Nbeal2 and its interactors in platelet formation and function.

Main Methods:

• Interactome analysis to identify Nbeal2 binding partners.
• Reverse immunoprecipitation to validate interactions with Dock7, Sec16a, and Vac14.
• Proximity ligation assays in human megakaryocytes.
• Subcellular localization studies of Nbeal2 and Dock7.
• Analysis of Dock7 levels and signaling in GPS platelets and Nbeal2-deficient mice.

Main Results:

• Nbeal2 interacts with Dock7, Sec16a, and Vac14.
• GPS-associated NBEAL2 mutations impair interactions with Dock7 and Vac14.
• Nbeal2 and Dock7 are physically proximal in megakaryocytes.
• Platelets from GPS patients and Nbeal2-deficient mice lack Dock7.
• Nbeal2 deficiency leads to Dock7 pathway dysregulation, affecting actin polymerization, platelet activation, and shape.

Conclusions:

• This study identifies key Nbeal2 interacting proteins, including Dock7.
• Dysregulation of the Dock7 signaling pathway is implicated in aberrant platelet formation in GPS.
• These findings provide novel insights into the molecular mechanisms underlying gray platelet syndrome.